|
|
|
|
::: GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
'World Aids Day' Commemorated by GeoVax with Hope and Promise ATLANTA, Dec.1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta-based biotechnology company developing human vaccines for diseases caused...
|
|
|
Performance of a Novel Human Immunodeficiency Virus (HIV) Type 1 Total Nucleic Acid-Based Real-Time PCR Assay
Stevens W et al.- The resulting clinical specificities and sensitivities of the new test were 100% and 99.7% for whole blood and DBS, respectively. The new test was characterized by its robustness, enhanced automation, and improved...
|
|
|
Aethlon Medical Discloses Initiation of Research Coverage
- Aethlon Medical, Inc.(OTCBB:AEMD) disclosed today that The Robins Group, an independent brokerage and investment banking firm, has initiated research coverage on the Company. The report was prepared and published by The Robins Group...
|
|
|
Aethlon Medical Discloses Initiation of Research Coverage
Aethlon Medical, Inc.(OTCBB:AEMD) disclosed today that The Robins Group, an independent brokerage and investment banking firm, has initiated research coverage on the Company. The report was prepared and published by The Robins Group and...
|
|
|
Bone Marrow Donor Meets Boy Whose Life he Saved
Gulf Coast Regional Blood Center Tears flowed recently when Donnie Syptak, 35, held in his arms the little boy whose life he saved by donating his bone marrow one year ago.It was the first time for Syptak to meet Trenton Platt, now 2, and...
|
|
|
GeoVax's phase-2a HIV/AIDS vaccine human trials to begin in North & South America
GeoVax Labs, Inc, an Atlanta based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced that the launch of its phase-2a Human Vaccine...
|
|
|
Medical Students See Red For HIV And AIDS, Australian Medical Students' Association
Medical students across Australia have rallied as part of a nation-wide effort to increase awareness of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS), a devastating spectrum of...
|
|
|
GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials To Begin In North And South America
GeoVax Labs, Inc.(OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced today that the...
|
|
|
International Fund Cuts Could Lead to AIDS Pandemic
The United Nations recently conducted an estimative study Adjust text size: The global financial crisis will also take its toll on human lives, if AIDS prevention funds are reduced by governments trying to maintain a positive economic...
|
|
|
GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
ATLANTA, Dec.1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (GOVX), an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents,...
|
|
|
GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
'It is of significant importance to report this major development on this very day in which the world commemorates WORLD AIDS DAY.Despite setbacks reported recently with other vaccine trials, our vaccine is progressing and paving...
|
|
|
GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
'World Aids Day' Commemorated by GeoVax with Hope and Promise ATLANTA, Dec.1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. , an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human ...
|
|
|
GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
'World Aids Day' Commemorated by GeoVax with Hope and Promise ATLANTA, Dec.1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. , an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human ...
|
|
|
GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
'World Aids Day' Commemorated by GeoVax with Hope and Promise ATLANTA, Dec.1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. , an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human ...
|
|
|
GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
'World Aids Day' Commemorated by GeoVax with Hope and Promise ATLANTA, Dec.1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. , an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human ...
|
|
|
GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
'World Aids Day' Commemorated by GeoVax with Hope and Promise ATLANTA, December 01, 2008 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc., an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV...
|
|
|
GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
'World Aids Day' Commemorated by GeoVax with Hope and Promise ATLANTA, Dec.1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTCBulletinBoard: GOVX) , an Atlanta-based biotechnology company developing human vaccines for diseases...
|
|
|
GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
ATLANTA, Dec.1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. , an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced...
|
|
|
GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
ATLANTA, Dec.1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX - News), an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and...
|
|
|
Immunological Recovery and Metabolic Disorders in Severe Immunodeficiency HIV Type 1-Infected Children on High
_ Immunological Recovery and Metabolic Disorders in Severe Immunodeficiency HIV Type 1-Infected Children on High.
|
|
|
AIDS Drugs Find Help in Selenium
The chemical helps slow down the replication of the virus Adjust text size: New find links the presence of higher amounts of the rare chemical selenium in the human bloodstream to a lower replication rate of the Human Immunodeficiency...
|
|
|
HIV infection goes up steadily in Slovenia
BELGRADE, Nov.27 (Xinhua) -- The Human Immunodeficiency Virus (HIV) infection rate has been going up steadily in Slovenia during the past years, Slovenia's medical officials said on Thursday. Head of the sexually transmitted...
|
|
|
HIV infection goes up steadily in Slovenia
BELGRADE, Nov.27 (Xinhua) -- The Human Immunodeficiency Virus (HIV) infection rate has been going up steadily in Slovenia during the past years, Slovenia's medical officials said on Thursday. Head of the sexually transmitted...
|
|
|
Column: HIV test should be mandatory during annual check ups
Source: The Famuan, Florida A&M U.Every year we go to the doctor for an annual check up, at least we should. Doctors usually check for our blood pressure, cholesterol, and vital signs. But what if a Human Immunodeficiency...
|
|
|
Human Immunodeficiency Virus-induced Uveitis: Intraocular and Plasma Human Immunodeficiency Virus-1 RNA Loads
_ Human Immunodeficiency Virus-induced Uveitis: Intraocular and Plasma Human Immunodeficiency Virus-1 RNA Loads.
|
